Clinical Trial: Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma

U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06940518) titled 'Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma' on April 15.

Brief Summary: To learn if ivonescimab can help to control previously treated, locally advanced or metastatic ccRCC.

Study Start Date: Oct. 09, 2025

Study Type: INTERVENTIONAL

Condition: Ivonescimab Clear Cell Renal Carcinoma

Intervention: DRUG: Ivonescimab

Given by IV

Recruitment Status: NOT_YET_RECRUITING

Sponsor: M.D. Anderson Cancer Center

Published by HT Digital Content Services with permission from Health Daily Digest....